(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS

The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Cette...

Full description

Saved in:
Bibliographic Details
Main Authors FYFE, MATTHEW COLIN THOR, ORTEGA MUNOZ, ALBERTO, ESTIARTE MARTINEZ, MARIA DE LOS ANGELES, VALLS VIDAL, NURIA, MARTINELL PEDEMONTE, MARC, KURZ, GUIDO, CASTRO PALOMINO LARIA, JULIO CESAR
Format Patent
LanguageEnglish
French
Published 20.10.2020
Subjects
ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to (hetero)aryl cyclopropylamine compounds, including particularly the compounds of formula (I) as described and defined herein, and their use in therapy, including, e.g., in the treatment or prevention of cancer, a neurological disease or condition, or a viral infection. Cette invention concerne des composés d'(hétéro)aryl-cyclopropylamine, comprenant en particulier les composés de formule (I) ci-décrits et ci-définis, et leur utilisation en thérapie, y compris, par ex., dans le traitement ou la prévention du cancer, d'une maladie ou affection neurologique, ou d'une infection virale.
Bibliography:Application Number: CA20122849564